SCF ENCYCLOPEDIA ENTRY

CEREBRAL VENOUS SINUS THROMBOSIS (POSTPARTUM)

SCF-RDOS Registry Code: SCF-RDOS-PPD-NEURO-005

Disease Type Classification: Postpartum Neurological Disorder → Cerebral Venous Thrombotic Syndrome → Cerebral Venous Sinus Thrombosis (CVST)

SCF Classification Status: Maternal Cerebral Venous Outflow Failure Syndrome

SCF Severity Classification: Neurovascular Perfusion and Intracranial Pressure Dysregulation Disorder

Adaptive Module Activation

Universal Core Module
Neurobiology Expansion
Cerebrovascular Biology Expansion
Venous Biology Expansion
Hemodynamic Biology Expansion
Coagulation Biology Expansion
Endothelial Biology Expansion
Immunology Expansion
Mitochondrial Biology Expansion
Connectomics Expansion
Critical Care Expansion
Maternal Survival Biology Expansion
SCF Pathophysiology Protocol (Extended Version)
SCF Universal Cross-System Analysis Module

1. SCOPE & POSITIONING

Definition

Cerebral Venous Sinus Thrombosis (CVST) is a cerebrovascular disorder characterized by thrombotic occlusion of the cerebral venous sinuses and/or cortical veins, resulting in impaired cerebral venous drainage, increased intracranial pressure, cerebral edema, venous infarction, intracranial hemorrhage, and neurological dysfunction.

The postpartum period represents one of the highest-risk physiological states for CVST because of persistent hypercoagulability, endothelial activation, dehydration, cesarean delivery, infection, hemorrhage, and inflammatory stress.

Within the SCF framework, CVST is classified as:

A neurovascular drainage failure syndrome characterized by obstruction of cerebral venous intelligence networks, impaired cerebral fluid dynamics, elevated intracranial pressure, venous ischemia, and progressive disruption of cerebral adaptive function.

2. SCOPE & CLINICAL POSITIONING

SCF Hierarchical Placement

Normal Cerebral Venous Drainage

↓

Postpartum Hypercoagulable State

↓

Venous Thrombus Formation

↓

Venous Outflow Obstruction

↓

Cerebral Venous Sinus Thrombosis

↓

Intracranial Pressure Elevation

↓

Venous Infarction / Hemorrhage

↓

Neurologic Dysfunction

Major Postpartum Associations

Hypercoagulable Disorders

Postpartum Hypercoagulability
Inherited Thrombophilia
Antiphospholipid Syndrome

Obstetric Disorders

Severe Postpartum Hemorrhage
Cesarean Delivery
Puerperal Infection
Preeclampsia
HELLP Syndrome

Critical Illness Disorders

Septic Shock
DIC
MODS
Maternal Critical Illness Syndrome

Neurologic Disorders

Postpartum Stroke
PRES
Intracerebral Hemorrhage
Seizure Disorders

3. ETIOPATHOGENIC CORE

Central SCF Principle

CVST develops when thrombotic obstruction impairs cerebral venous drainage beyond compensatory capacity, producing venous congestion, elevated intracranial pressure, reduced cerebral perfusion, and secondary neuronal injury.

The syndrome reflects failure of:

Cerebral venous outflow
Hemostatic regulation
Endothelial homeostasis
Intracranial pressure regulation
Cerebral perfusion balance
Neurovascular communication networks

Core SCF Equation

Postpartum Hypercoagulability

Venous Thrombosis

Cerebral Drainage Failure

Cerebral Venous Sinus Thrombosis

4. ETIOLOGY AND TRIGGER CLUSTERS

Cluster A — Hypercoagulable CVST

Associated Conditions:

Physiologic postpartum hypercoagulability
Factor V Leiden
Prothrombin gene mutation
Protein C deficiency
Protein S deficiency

Primary Failure:

Excessive thrombogenesis

Cluster B — Obstetric CVST

Associated Conditions:

Cesarean delivery
Severe postpartum hemorrhage
Prolonged labor

Primary Failure:

Hemodynamic and coagulation imbalance

Cluster C — Inflammatory CVST

Associated Conditions:

Endometritis
Puerperal sepsis
Systemic inflammatory states

Primary Failure:

Endothelial activation

Cluster D — Autoimmune-Thrombotic CVST

Associated Conditions:

Antiphospholipid syndrome
Systemic lupus erythematosus

Primary Failure:

Pathologic coagulation activation

Cluster E — Critical Illness CVST

Associated Conditions:

DIC
Septic shock
MODS

Primary Failure:

Systemic coagulation dysregulation

5. SCF FAULT ARCHITECTURE

Tier I — Hypercoagulable Activation

Events:

Coagulation cascade enhancement
Endothelial activation
Reduced fibrinolysis

Result:

Thrombotic susceptibility

Tier II — Venous Thrombus Formation

Features:

Sinus thrombosis
Cortical vein thrombosis

Result:

Venous drainage impairment

Tier III — Cerebral Venous Congestion

Features:

Increased venous pressure
Reduced cerebral outflow

Result:

Intracranial pressure elevation

Tier IV — Cerebral Venous Sinus Thrombosis

Features:

Headache
Seizures
Neurologic deficits

Result:

Clinical CVST

Tier V — Secondary Brain Injury

Features:

Venous infarction
Cerebral edema
Hemorrhagic conversion

Result:

Progressive neurologic damage

Tier VI — Neurocritical Failure

Features:

Herniation
Coma
Multi-system destabilization

Result:

Maternal survival threat

6. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Affected Pathways:

Coagulation regulation
Endothelial resilience
Inflammatory signaling
Fibrinolytic control

Transcriptomics

Activation of:

Prothrombotic pathways
Cytokine signaling
Endothelial injury cascades

Proteomics

Elevated Biomarkers:

D-dimer
von Willebrand Factor (vWF)
IL-6
TNF-α
Fibrin degradation products

Metabolomics

Features:

Cerebral energy stress
Lactate accumulation
Oxidative injury

Endotheliomics

Features:

Glycocalyx injury
Endothelial dysfunction
Procoagulant surface activation

Connectomics

Features:

Cerebral network disruption
Functional connectivity impairment

Mitochondriomics

Features:

Neuronal ATP depletion
Bioenergetic instability

7. SCF PATHOGENESIS FLOW

Postpartum Hypercoagulability

↓

Endothelial Activation

↓

Venous Sinus Thrombosis

↓

Venous Outflow Obstruction

↓

Cerebral Venous Congestion

↓

Intracranial Pressure Elevation

↓

Reduced Cerebral Perfusion

↓

Venous Infarction

↓

Seizures / Neurologic Dysfunction

↓

CVST

↓

Recovery, Disability, or Death

8. SCF FUNCTIONAL MATRIX

System	Early Phase	Advanced Phase
Venous System	Thrombosis	Outflow Failure
Cerebrovascular	Congestion	Infarction
Neurologic	Headache	Severe Deficits
Cognitive	Mild Dysfunction	Impairment
Intracranial Dynamics	Pressure Elevation	Herniation Risk
Systemic	Compensation	Critical Illness

9. SCF TRINITY FRAMEWORK

Structural Integrity Failure

Affected Structures:

Superior sagittal sinus
Transverse sinus
Sigmoid sinus
Cortical veins

Primary Failure:

Loss of venous drainage architecture

Energetic Integrity Failure

Affected Systems:

Cerebral oxygen delivery
Neuronal ATP production
Neurovascular metabolic coupling

Primary Failure:

Regional cerebral energy deficit

Informational Integrity Failure

Affected Systems:

Neural communication pathways
Neurovascular regulation systems
Connectomic processing networks

Primary Failure:

Disrupted cerebral information flow

10. CLINICAL PHENOTYPES

Phenotype A — Intracranial Hypertension Dominant

Characteristics:

Severe headache
Papilledema
Visual disturbances

Phenotype B — Seizure-Dominant CVST

Characteristics:

Focal seizures
Generalized seizures
Cortical irritation

Phenotype C — Venous Infarction Dominant

Characteristics:

Focal neurologic deficits
Motor weakness
Speech impairment

Phenotype D — Hemorrhagic CVST

Characteristics:

Intracerebral hemorrhage
Rapid neurologic deterioration

Phenotype E — Fulminant Neurocritical CVST

Characteristics:

Coma
Massive edema
Herniation risk

11. SCF PATHOPHYSIOLOGY PROTOCOL — EXTENDED VERSION

Etiopathogenic Core

Thrombotic obstruction of cerebral venous drainage resulting in progressive intracranial pressure dysregulation and secondary neuronal injury.

SCF Fault Domains

Hypercoagulability
Venous thrombosis
Venous congestion
Intracranial hypertension
Cerebral edema
Venous infarction
Neurologic dysfunction

Trigger → Symptomatology → Fault Mapping

Trigger	Manifestation	SCF Tier
Hypercoagulability	Thrombus formation	I-II
Venous obstruction	Congestion	III
Elevated ICP	Headache	IV
Infarction	Neurologic deficits	V
Herniation	Survival threat	VI

12. SCF THERAPEUTIC MECHANISMS (PCR BRAID)

PREVENTATIVE

Objectives

Prevent cerebral venous thrombosis.

Targets:

Risk-factor identification
Thromboprophylaxis
Early mobilization
Hydration optimization

CURATIVE

Objectives

Restore cerebral venous drainage and prevent secondary brain injury.

Targets:

Thrombus burden
Venous congestion
Intracranial hypertension
Cerebral edema

Clinical Interventions:

Anticoagulation therapy
Neurocritical care
Seizure management
Intracranial pressure control

RESTORATIVE

Objectives

Restore neurovascular function and neurologic resilience.

Targets:

Neuroplasticity
Cognitive recovery
Functional reintegration
Cerebral network restoration

Potential SCF Strategies:

Neurovascular regenerative therapeutics
Endothelial restoration platforms
Precision neurorehabilitation systems
Mitochondrial support technologies

13. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Common Symptoms

Severe headache
Seizures
Focal neurologic deficits
Visual disturbances
Altered mental status

Neuroimaging

Preferred Studies:

MRI with MR Venography (MRV)
CT Venography (CTV)

Laboratory Evaluation

CBC
Coagulation profile
D-dimer
Thrombophilia assessment (selected cases)

Treatment

Acute Management

Therapeutic anticoagulation
ICU monitoring when severe
Seizure treatment
ICP management

Advanced Management

Endovascular thrombectomy (selected cases)
Decompressive surgery (rare severe cases)

14. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Coagulation

D-dimer
Fibrin degradation products

Endothelial Injury

vWF
Soluble thrombomodulin

Inflammation

IL-6
TNF-α
CRP

Neurologic Injury

GFAP
NSE
S100B

Clinical Endpoints

Primary

Recanalization and neurologic recovery

Secondary

Seizure prevention
Functional independence
Cognitive preservation
Maternal survival

15. PROJECT RHENOVA — INTEGRATION PATHWAYS

RHENOVA-A

Cerebral Venous Recanalization

RHENOVA-B

Endothelial Stabilization

RHENOVA-C

Intracranial Pressure Optimization

RHENOVA-D

Neuroinflammation Control

RHENOVA-E

Neural Network Recovery

RHENOVA-F

Functional Reintegration

16. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Maternal thrombotic biomarker panels

Priority 2

Endothelial resilience therapeutics

Priority 3

AI-assisted CVST prediction models

Priority 4

Neurovascular recanalization technologies

Priority 5

Mitochondrial neuroprotection platforms

Priority 6

Precision postpartum neurorehabilitation

17. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Neurons experience metabolic stress due to impaired venous drainage and secondary perfusion abnormalities.

Tissue Layer

Cerebral tissue becomes congested, edematous, and vulnerable to ischemic and hemorrhagic injury.

Organ Layer

The brain loses optimal regulation of pressure, perfusion, and information processing.

System Layer

Coagulation, vascular, neurologic, immune, and metabolic systems become progressively desynchronized.

Whole-Organism Layer

The maternal organism experiences failure of cerebral drainage intelligence networks, leading to impaired cognition, movement, consciousness, and adaptive function.

18. SCF LAYMAN’S SUMMARY

Cerebral Venous Sinus Thrombosis is a rare but serious condition in which a blood clot blocks the veins that drain blood from the brain.

In the SCF framework, CVST is viewed as a failure of the brain’s drainage system. Blood becomes trapped within the brain’s venous network, increasing pressure and potentially causing swelling, stroke-like symptoms, seizures, or bleeding.

Common symptoms include:

Severe headache
Seizures
Vision problems
Weakness or numbness
Difficulty speaking
Confusion

Prompt diagnosis and treatment are critical because most patients can recover well if the clot is identified early and treated appropriately.

SCF-RDOS INDICATION SUMMARY

Parameter	Classification
Disease	Cerebral Venous Sinus Thrombosis (CVST)
Registry Code	SCF-RDOS-PPD-NEURO-005
Disease Type	Maternal Cerebral Venous Outflow Failure Syndrome
Adaptive Modules Activated	Neurobiology + Venous Biology + Coagulation Biology + Critical Care
SCF Fault Tier	I–VI
Primary Systems	Cerebrovascular, Venous, Neurologic, Hemostatic
Principal Fault Nodes	Hypercoagulability, Venous Thrombosis, Venous Congestion, Intracranial Hypertension
Mortality Risk	Moderate to High
Morbidity Risk	High
Disability Risk	Moderate to High
Chronicity Risk	Moderate
SCF-PCR Applicability	Preventative, Curative, Restorative

INDEX

SCF Master Registry Classification

SCF-RDOS-PPD-NEURO-001 — Postpartum Stroke
SCF-RDOS-PPD-NEURO-003 — Intracerebral Hemorrhage (ICH)
SCF-RDOS-PPD-NEURO-004 — Subarachnoid Hemorrhage (SAH)
SCF-RDOS-PPD-NEURO-005 — Cerebral Venous Sinus Thrombosis (CVST)
SCF-RDOS-PPD-NEURO-002 — Postpartum Posterior Reversible Encephalopathy Syndrome (PRES)

Domain Pathway

Postpartum Disorders → Neurologic Disorders → Cerebral Venous Thrombotic Syndromes → Cerebral Venous Sinus Thrombosis

Adaptive Modules Applied

Universal Core Module + Neurobiology Expansion + Cerebrovascular Biology Expansion + Venous Biology Expansion + Hemodynamic Biology Expansion + Coagulation Biology Expansion + Endothelial Biology Expansion + Critical Care Expansion + Maternal Survival Biology Expansion

SCF Encyclopedia Series

Maternal Postpartum Disorders Encyclopedia (Neurovascular Medicine, Cerebral Venous Biology, Thrombosis Science, Neurocritical Care & Maternal Survival Biology Volume) — Version 1.0.0